News for Bruker Corporation (BRKR.MX)

[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $8

Bruker Corporation (BRKR) has announced its financial projections for the first quarter, anticipating an approximate 10% increase in reported revenue compared t

Bruker (BRKR) anticipates Q1 2025 revenue between $795 million to $800 million, surpassing company and consensus expectations. The company reported appr

At the [url="]ESCMID Global 2025[/url] conference, [url="]Bruker´s[/url] Microbiology and Infection Diagnostics division is announcing the expansion of its mi

Bruker (BRKR) has announced a majority investment in Ridom GmbH, enhancing its microbiology diagnostic capabilities. The collaboration introduce

In a recent financial analysis, Barclays has adjusted its price target for Bruker Corporation (BRKR), lowering it from $60 to $50. Despite this reduction, the f

Bruker Corporation presents a potential long-term opportunity despite a 60% stock drop. Click here to read more on BRKR and its projected growth.

At the Joint ENC-ISMAR Conference 2025, [url="]Bruker Corporation[/url], the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, annou

We recently compiled a list of the 12 Oversold Value Stocks to Buy According to Hedge Funds.

Value stocks, as defined by their low forward P/E ratio, can present compelling investment opportunities, especially when they've become oversold due to negative market sentiment or temporary economic...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against...

[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDONâ„¢, a high-performance 3D X-ray microscope (XRM) using micro-C

The London Company, an investment management company, released “The London Company SMID Cap Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. U.S.

At the [url="]21st Annual US HUPO Conference[/url], [url="]Bruker Corporation[/url] (Nasdaq: BRKR) announces significant advances in 4D-Proteomicsâ„¢ performan

Bruker Corporation (NASDAQ:BRKR) Q4 2024 Results Conference Call February 13, 2025 8:30 AM ETCompany ParticipantsJoe Kostka - Director, Investor...

[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024. Frank

[url="]Bruker Corporation[/url] (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Th

Financial writer recommends buying Bruker Corporation (BRKR) due to undervaluation, strategic acquisitions, and growth potential by FY2025.

[url="]Bruker Corporation[/url] (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank